Christopher J. Coughlin, Director at ALEXION PHARMACEUTICALS INC (ALXN), bought 2,000 shares at $117.10 ($234K) on 2017-06-15, disclosed to the SEC on 2017-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| AGN | BUY | 2018-09-07 | $3.5M | — | Filing → |
| ALXN | BUY | 2018-05-02 | $1.2M | — | Filing → |